Many U.S. Adults Still Have Misconceptions About Skin Cancer Risk
By Elana Gotkine HealthDay Reporter
WEDNESDAY, March 26, 2025 -- About two-thirds of U.S. adults report no sunburns in the past year, with significant associations seen between the number of sunburns and sociodemographic factors, according to a study recently published online in the American Journal of Lifestyle Medicine.
Madison Etzel, from Florida Atlantic University in Boca Raton, and colleagues obtained information from the 2022 Health Information National Trends Survey 6 to explore sociodemographic characteristics, cancer risk perceptions, and behaviors surrounding sunburns. Associations between the number of sunburns and sociodemographic variables were examined. Data were included for 6,252 participants who were surveyed.
The researchers found that most respondents felt very confident or completely confident about their ability to take good care of their own health (44.0 and 27.3 percent, respectively). Most respondents were somewhat or slightly worried about getting cancer and few were extremely worried about getting cancer (28.3, 27.3, and 9.1 percent, respectively). Overall, 2.1, 30.3, and 67.6 percent reported experiencing more than six, one to five, and no sunburns, respectively, in the past 12 months. Significant associations were reported between the number of sunburns and age, gender, occupation status, marital status, education, Hispanic origin, race, and income level.
"Our study underscores the importance of raising awareness about skin cancer susceptibility as we found that all sociodemographic factors were significantly linked to the number of reported sunburns in the past year," Etzel said in a statement.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted March 2025
Read this next
Presurgical Immunotherapy Offers Long-Term Benefit in Melanoma
FRIDAY, July 18, 2025 -- Neoadjuvant systemic treatment (NST) followed by adjuvant treatment with nivolumab and relatlimab offers long-term benefit in adults with stage III/IV...
Immune Checkpoint Inhibitor Affordability Tied to Widening Survival Disparity
FRIDAY, July 11, 2025 -- The introduction of immune checkpoint inhibitors (ICIs) was associated with a widening survival disparity between those with private insurance and those...
AI Better for Tumor-Infiltrating Lymphocyte Quantification in Melanoma Than Traditional Methods
TUESDAY, July 8, 2025 -- For tumor-infiltrating lymphocyte (TIL) quantification in melanoma, an artificial intelligence (AI) algorithm demonstrates superior reproducibility and...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.